External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience CNS 2024
Roche and Genentech at

CNS 2024

November 11 - November 14
San Diego, California
childneurologysociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Nov 10 / Roche and Genentech
Risdiplam▼ clinical trial outcomes in individuals with spinal muscular atrophy (SMA) and four SMN2 copies
This poster presents efficacy and safety data from risdiplam▼ clinical trials that explored the impact of risdiplam▼ on outcomes in symptomatic and presymptomatic individuals with SMA and four SMN2 copies.
Neuroscience Spinal Muscular Atrophy CNS-2024
08:30 PM
Duration 2hrs San Diego, California
Risdiplam▼ clinical trial outcomes in individuals with spinal muscular atrophy (SMA) and four SMN2 copies
Florence Toy, Enrico Bertini, Claudia Chiriboga, Eugenio Mercuri, Travis Dickendesher, Yue Li, Carmen Martin, Laura Palfreeman, Selina Tam, Wai Yin Yeung
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.